Drawing for ILLUSTRIS

USPTO serial 87579019

ILLUSTRIS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
YONTEF, DAVID ERIC
Law office
TMO LAW OFFICE 118- EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ILLUSTRIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Technological drug delivery platforms, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of therapeutic pharmaceutical molecules through various tissue structures to optimize absorption in the skin, eyes, hair, bones, teeth and mucosal surfaces of humans and animals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceutical molecules through various tissue structures for use in the cosmetic and veterinary medicine industries; pharmaceutical drug delivery agents consisting of compounds that facilitate topical delivery of a wide range of therapeutic pharmaceutical agents; pharmaceutical preparations for the treatment of skin, eye, hair, bone, tooth and mucosal disorders and conditions; dermatological pharmaceutical products; ocular pharmaceuticals; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders in humans and animalsACTIVENov 2, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Nov 6, 2020MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 5, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 21, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 21, 2020CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 14, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE
Apr 14, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 31, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 31, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 31, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 27, 2020IUAFUSE AMENDMENT FILED
Mar 27, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 28, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 26, 2019EX3GSOU EXTENSION 3 GRANTED
Sep 26, 2019EXT3SOU EXTENSION 3 FILED
Sep 26, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 26, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 26, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 25, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 25, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 29, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 27, 2019EX2GSOU EXTENSION 2 GRANTED
Mar 27, 2019EXT2SOU EXTENSION 2 FILED
Mar 27, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 11, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 29, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 27, 2018EX1GSOU EXTENSION 1 GRANTED
Sep 27, 2018EXT1SOU EXTENSION 1 FILED
Sep 27, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 27, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 30, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 30, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 10, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 26, 2017ALIEASSIGNED TO LIE
Dec 8, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Dec 8, 2017XAECEXAMINER'S AMENDMENT ENTERED
Dec 8, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 8, 2017GNEAEXAMINERS AMENDMENT E-MAILED
Dec 8, 2017CNEAEXAMINERS AMENDMENT -WRITTEN
Nov 28, 2017DOCKASSIGNED TO EXAMINER
Aug 28, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 25, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance